Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 6Terminated 2Recruiting 2Active not recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 69Carcinoma, Non-Small-Cell Lung 62Stomach Neoplasms 32Prostatic Neoplasms 21Nasopharyngeal Carcinoma 20Lung Neoplasms 20Squamous Cell Carcinoma of Head and Neck 11Esophageal Neoplasms 11Neoplasm Metastasis 8Head and Neck Neoplasms 7Inflammatory Breast Neoplasms 6Pancreatic Neoplasms 5Neoplasms 5HER2-positive Breast Cancer 5Adenocarcinoma 5Triple Negative Breast Neoplasms 4Ovarian Neoplasms 4NSCLC 4Carcinoma, Squamous Cell 4Sarcoma 3Nasopharyngeal Neoplasms 3Hypopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Ovarian Epithelial 3Breast Diseases 3Adenocarcinoma of Lung 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tongue Neoplasms 2Squamous Cell Lung Cancer 2

Interventions

Injections 4Paclitaxel 2toripalimab 1tesetaxel 1sintilimab 1satraplatin 1pembrolizumab 1liposomal doxorubicin 1isophosphamide mustard 1fluzoparib 1duvelisib 1camrelizumab 1apatinib 1anlotinib 1Vinorelbine 1Sirolimus 1Saline Solution 1SKLB1028 1Radiotherapy 1Panobinostat 1Lenalidomide 1Irinotecan 1Everolimus 1Docetaxel 1Carboplatin 1Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Solid Tumors × Docetaxel × Clear all
NCT04811118 2022-01-31

The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
27 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡